Unlock Innovation.
Unleash Potential.
Ajinomoto Bio-Pharma Services is a global network of specialized CDMOs and enabling technologies, bringing together deep modality expertise, advanced technologies, and scientific innovation to help develop and manufacture novel and complex medicines for biopharma innovators and the patients they serve.
Our CDMO Services
Find the support your program needs across small molecules, oligonucleotides, peptides, gene therapies, proteins, and bioconjugates.
Small Molecule Manufacturing
APIs and intermediates, including specialized solutions for complex chemistry.
Oligonucleotide Manufacturing
Solid-phase synthesis and proprietary AJIPHASE™ liquid-phase technology.
Gene Therapy Manufacturing
AAV development and cGMP manufacturing through Forge Biologics.
Protein Manufacturing
Recombinant protein production through secretion for simplified purification and higher purity.
ADC & Bioconjugation Services
Next generation site-specific conjugation and linker technologies for ADCs and bioconjugates.
Improving the Health of Humankind
Our mission is to help improve the health of humankind by advancing manufacturing and development solutions that enable our partners to bring therapies to patients around the world.
How we deliver matters just as much as what we deliver. Across our global network, our commitment to quality, operational excellence, sustainability, and dependable partnership gives our partners confidence at every stage.
Building on a Legacy of Scientific Innovation
For more than a century, Ajinomoto Group has pioneered science to solve complex challenges and create new possibilities for people, society, and the planet.
That legacy of scientific rigor, R&D excellence, and continuous innovation shapes how we approach biopharma development and manufacturing today, from advancing processes for increasingly complex medicines to creating proprietary technologies such as AJIPHASE™, AJICAP™, CORYNEX™ that give biopharma innovators new ways to advance their science.
Specialized expertise with global scale
50+
Years of CDMO Experience
2,000+
Employees Worldwide
4
Countries of Operations
7
Specialized Facilities
